News | Cardiovascular Ultrasound | April 16, 2019

Ebit and DiA Imaging Analysis Partner on AI-based Cardiac Ultrasound Analysis

Agreement brings DiA’s LVivo Toolbox for echo analysis and reporting to Ebit’s Suitestensa CVIS

Ebit and DiA Imaging Analysis Partner on AI-based Cardiac Ultrasound Analysis

April 16, 2019 — DiA Imaging Analysis has partnered with the Italian healthcare IT company Ebit (Esaote Group), to offer DiA’s LVivo Cardiac Toolbox as an integrated part of Ebit's Suitestensa CVIS (cardiovascular information system). The LVivo Cardiac Toolbox is designed to analyze cardiac ultrasound images based on more objective and reproducible information, as opposed to manual measurement or visual analysis methods that are currently being used.

DiA’s LVivo Toolbox is based on advanced pattern recognition and machine learning algorithms that automatically imitate the way the human eye detects borders and motion. DiA's automated tools deliver fast and accurate clinical indications to support the decision-making process. LVivo is both vendor-neutral and easily implementable as part of the daily evaluation workflow. The integration of the LVivo toolbox will enable the support of DICOM clips from all ultrasound devices used at the lab, making LVivo AI analysis accessible to all lab users using the picture archiving and communication system (PACS) and ultimately improving patient care.

Ebit’s cardiovascular software Suitestensa is a vendor-neutral comprehensive enterprise platform that allows physicians to archive, manage and share data reports and clinical images produced by any cardiological equipment. Ebit will offer the LVivo Toolbox as an integrated part of its PACS viewer. The integration has been designed around the same human interface of Suitestensa CVIS in order to assure the best user experience and efficient workflow.

For more information: www.dia-analysis.com, www.esaote.com

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Videos | Computed Tomography (CT) | July 19, 2019
Quynh Truong, M.D., MPH, associate professor of radio
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Graphic courtesy Pixabay

Graphic courtesy Pixabay

Feature | Artificial Intelligence | July 15, 2019 | By Greg Freiherr
Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient.
Videos | Artificial Intelligence | July 12, 2019
Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by...
Videos | Digital Pathology | July 11, 2019
Toby Cornish, M.D., Ph.D., associate professor and medical director of informatics at the University of Colorado Scho
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).